Serial interval
The serial interval in the epidemiology of communicable (infectious) diseases is the time between successive cases in a chain of transmission.[1]
The serial interval is generally estimated from the interval between clinical onsets (if observable), in which case it is the 'clinical onset serial interval'. It could in principle be estimated by the time interval between infection and subsequent transmission. If the typical time from the first person's clinical onset to when they infect another is TA, and the incubation period of a subsequent case is IB, then the clinical onset serial interval is TA + IB. More realistically, the calculation would use the observed frequency distribution of times from onset of a single primary case to that of its associated secondary cases.[2] If the distribution of timing of transmission events during the infectious period is not skewed around its mean, then the average serial interval is calculated as the sum of the average latent period (from infection to infectiousness) and half the average infectious period.[citation needed]
Serial intervals can vary widely, especially for lifelong diseases such as HIV infection, chickenpox, and herpes. The serial interval for SARS was 7 days.[3] For the original strain of COVID-19, a 2020 review of the published literature shows its serial interval to be 4-8 days.[4]
Related but distinct quantities include the 'average transmission interval' sum of average latent and infectious period, the 'incubation period' between infection and disease onset, and the 'latent period' between infection and infectiousness.[citation needed]
References
- ^ Last J.M. (2001) A Dictionary of Epidemiology, Oxford University Press.
- ^ Fine, P. E. M. (2003). "The Interval between Successive Cases of an Infectious Disease". American Journal of Epidemiology. 158 (11): 1039–1047. doi:10.1093/aje/kwg251. PMID 14630599.
- ^ Lipsitch, M.; Cohen, T.; Cooper, B.; Robins, J. M.; Ma, S.; James, L.; Gopalakrishna, G.; Chew, S. K.; Tan, C. C.; Samore, M. H.; Fisman, D.; Murray, M. (2003). "Transmission Dynamics and Control of Severe Acute Respiratory Syndrome" (PDF). Science. 300 (5627): 1966–1970. Bibcode:2003Sci...300.1966L. doi:10.1126/science.1086616. PMC 2760158. PMID 12766207.
- ^ Park, Minah; Cook, Alex R.; Lim, Jue Tao; Sun, Yinxiaohe; Dickens, Borame L. (2020-03-31). "A Systematic Review of COVID-19 Epidemiology Based on Current Evidence". Journal of Clinical Medicine. 9 (4): 967. doi:10.3390/jcm9040967. ISSN 2077-0383. PMC 7231098. PMID 32244365.
- v
- t
- e
Agent |
|
---|---|
Host |
|
Environment |
|
Basic concepts | |||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Modes |
| ||||||||||||||||||||||||||||
Modelling | |||||||||||||||||||||||||||||
Occurrence in population |
location
- Respiratory
- Gastrointestinal
- Genitourinary
- Nervous system
- Skin
- Soft tissue
- Bone
- Joint
- Cardiovascular
- Systemic/Generalized
- Blood
- Tooth
- Mouth
- Fetus
- Eye
and Control
measures
Pharmaceutical | |
---|---|
Non- pharmaceutical |
|
infections
- Antigenic drift
- Antigenic shift
- Antimicrobial resistance surveillance
- Biosecurity
- CRISPR
- Disease X
- Emergent virus
- Evolutionary epidemiology
- Genetic epidemiology
- Global Health Initiatives
- Microbial phylogenetics
- One Health Model
- Genomic reassortment
- Re-emerging disease
- Reverse zoonosis
- Selection pressure
- Synthetic biology
- Viral phylodynamics
- Discovery
- Eradication
- Economics of Infectious Diseases
- Infectious disease (medical specialty)
- Infectious disease informatics
- Microbial bioterrorism
- Pandemic prevention
- Tropical disease
![]() | This infectious disease article is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e